MX2022014326A - Proteinas multiespecificas. - Google Patents
Proteinas multiespecificas.Info
- Publication number
- MX2022014326A MX2022014326A MX2022014326A MX2022014326A MX2022014326A MX 2022014326 A MX2022014326 A MX 2022014326A MX 2022014326 A MX2022014326 A MX 2022014326A MX 2022014326 A MX2022014326 A MX 2022014326A MX 2022014326 A MX2022014326 A MX 2022014326A
- Authority
- MX
- Mexico
- Prior art keywords
- proteins
- multispecific proteins
- nucleic acids
- multispecific
- pharmaceutical compositions
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 4
- 108090000623 proteins and genes Proteins 0.000 title abstract 4
- 102000039446 nucleic acids Human genes 0.000 abstract 3
- 108020004707 nucleic acids Proteins 0.000 abstract 3
- 150000007523 nucleic acids Chemical class 0.000 abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 102000008102 Ankyrins Human genes 0.000 abstract 1
- 108010049777 Ankyrins Proteins 0.000 abstract 1
- 101150013553 CD40 gene Proteins 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 abstract 1
- 102000023732 binding proteins Human genes 0.000 abstract 1
- 108091008324 binding proteins Proteins 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/485—Exopeptidases (3.4.11-3.4.19)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/14—Dipeptidyl-peptidases and tripeptidyl-peptidases (3.4.14)
- C12Y304/14005—Dipeptidyl-peptidase IV (3.4.14.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
La presente invención se refiere a proteínas multiespecíficas que comprenden dominios diseñados con repeticiones de anquirina con especificidad de unión para diferentes dianas, tales como, por ejemplo, CD40 y FAP. Además, la invención se refiere a ácidos nucleicos que codifican dichas proteínas multiespecíficas, composiciones farmacéuticas que comprenden dichas proteínas multiespecíficas o ácidos nucleicos, y el uso de las citadas proteínas de unión, ácidos nucleicos o composiciones farmacéuticas en métodos para tratar o diagnosticar enfermedades, tales como cáncer, en un mamífero, con inclusión de un ser humano.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20174847 | 2020-05-14 | ||
EP20181498 | 2020-06-22 | ||
PCT/EP2021/062860 WO2021229067A1 (en) | 2020-05-14 | 2021-05-14 | Multispecific proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2022014326A true MX2022014326A (es) | 2023-02-09 |
Family
ID=75904957
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2022014326A MX2022014326A (es) | 2020-05-14 | 2021-05-14 | Proteinas multiespecificas. |
Country Status (13)
Country | Link |
---|---|
US (1) | US20210395318A1 (es) |
EP (1) | EP4149959A1 (es) |
JP (1) | JP2023528204A (es) |
KR (1) | KR20230022176A (es) |
CN (1) | CN115768786A (es) |
AU (1) | AU2021271129A1 (es) |
BR (1) | BR112022023049A2 (es) |
CA (1) | CA3178785A1 (es) |
CO (1) | CO2022017445A2 (es) |
IL (1) | IL298168A (es) |
MX (1) | MX2022014326A (es) |
TW (1) | TW202208408A (es) |
WO (1) | WO2021229067A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114929730A (zh) | 2019-12-11 | 2022-08-19 | 分子合作伙伴股份公司 | 重组肽-mhc复合物结合蛋白及其生成和用途 |
EP3957649A1 (en) | 2020-08-18 | 2022-02-23 | Athebio AG | Improved n-terminal capping modules of ankyrin repeat domains |
US11981710B2 (en) | 2020-08-18 | 2024-05-14 | Athebio Ag | N-terminal capping modules of ankyrin repeat domains |
WO2022190016A1 (en) | 2021-03-09 | 2022-09-15 | Molecular Partners Ag | Novel darpin based multi-specific t-cell engagers |
WO2023110983A1 (en) * | 2021-12-14 | 2023-06-22 | Molecular Partners Ag | Designed repeat domains with dual binding specificity and their use |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8601597D0 (en) | 1986-01-23 | 1986-02-26 | Wilson R H | Nucleotide sequences |
CA2421447C (en) | 2000-09-08 | 2012-05-08 | Universitat Zurich | Collections of repeat proteins comprising repeat modules |
AR039067A1 (es) | 2001-11-09 | 2005-02-09 | Pfizer Prod Inc | Anticuerpos para cd40 |
WO2005063815A2 (en) | 2003-11-12 | 2005-07-14 | Biogen Idec Ma Inc. | Fcϝ receptor-binding polypeptide variants and methods related thereto |
CA2700391A1 (en) | 2007-09-24 | 2009-04-02 | University Of Zuerich | Designed armadillo repeat proteins |
ES2836948T3 (es) | 2008-11-03 | 2021-06-28 | Molecular Partners Ag | Proteínas de unión que inhiben la interacción del receptor de VEGF-A |
EP2483316A1 (en) | 2009-10-02 | 2012-08-08 | Ludwig Institute for Cancer Research Ltd. | Anti-fibroblast activation protein antibodies and methods and uses thereof |
TWI510246B (zh) | 2010-04-30 | 2015-12-01 | Molecular Partners Ag | 抑制vegf-a受體交互作用的經修飾結合性蛋白質 |
EP2643349B1 (en) | 2010-11-26 | 2019-09-04 | Molecular Partners AG | Designed repeat proteins binding to serum albumin |
WO2014001442A1 (en) | 2012-06-28 | 2014-01-03 | Molecular Partners Ag | Designed ankyrin repeat proteins binding to platelet-derived growth factor |
EP2738180A1 (en) | 2012-11-30 | 2014-06-04 | Molecular Partners AG | Binding proteins comprising at least two binding domains against HER2. |
US11453708B2 (en) | 2013-05-31 | 2022-09-27 | Molecular Partners Ag | Designed ankyrin repeat proteins binding to hepatocyte growth factor |
WO2016156596A1 (en) | 2015-04-02 | 2016-10-06 | Molecular Partners Ag | Designed ankyrin repeat domains with binding specificity for serum albumin |
MY196882A (en) | 2016-09-22 | 2023-05-08 | Molecular Partners Ag | Recombinant binding proteins and their use |
SG11201908787WA (en) * | 2017-04-04 | 2019-10-30 | Hoffmann La Roche | Novel bispecific antigen binding molecules capable of specific binding to cd40 and to fap |
SG11202102477QA (en) * | 2018-10-01 | 2021-04-29 | Hoffmann La Roche | Bispecific antigen binding molecules comprising anti-fap clone 212 |
-
2021
- 2021-05-14 CN CN202180044299.9A patent/CN115768786A/zh active Pending
- 2021-05-14 CA CA3178785A patent/CA3178785A1/en active Pending
- 2021-05-14 IL IL298168A patent/IL298168A/en unknown
- 2021-05-14 EP EP21725187.5A patent/EP4149959A1/en active Pending
- 2021-05-14 JP JP2022568689A patent/JP2023528204A/ja active Pending
- 2021-05-14 WO PCT/EP2021/062860 patent/WO2021229067A1/en unknown
- 2021-05-14 AU AU2021271129A patent/AU2021271129A1/en active Pending
- 2021-05-14 MX MX2022014326A patent/MX2022014326A/es unknown
- 2021-05-14 US US17/302,898 patent/US20210395318A1/en active Pending
- 2021-05-14 TW TW110117538A patent/TW202208408A/zh unknown
- 2021-05-14 BR BR112022023049A patent/BR112022023049A2/pt unknown
- 2021-05-14 KR KR1020227043615A patent/KR20230022176A/ko active Search and Examination
-
2022
- 2022-12-02 CO CONC2022/0017445A patent/CO2022017445A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
IL298168A (en) | 2023-01-01 |
BR112022023049A2 (pt) | 2022-12-20 |
TW202208408A (zh) | 2022-03-01 |
WO2021229067A1 (en) | 2021-11-18 |
US20210395318A1 (en) | 2021-12-23 |
CN115768786A (zh) | 2023-03-07 |
AU2021271129A9 (en) | 2023-03-02 |
EP4149959A1 (en) | 2023-03-22 |
CA3178785A1 (en) | 2021-11-18 |
JP2023528204A (ja) | 2023-07-04 |
AU2021271129A1 (en) | 2022-12-15 |
CO2022017445A2 (es) | 2023-02-16 |
KR20230022176A (ko) | 2023-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2022014326A (es) | Proteinas multiespecificas. | |
NZ754051A (en) | Novel antibodies and uses thereof | |
SA518400424B1 (ar) | جزيئات الجسم المضاد لعلاج السرطان | |
MX2022007122A (es) | Dominios de repetición de anquirina diseñados con residuos de superficie alterados. | |
MX2019001920A (es) | Arn la terapia contra el cancer. | |
MX2019011215A (es) | Ácidos nucleicos que codifican proteínas asociadas a crispr y usos de los mismos. | |
MX2019003298A (es) | Proteinas de union recombinantes y sus usos. | |
MX2017014082A (es) | Nuevas proteinas especificas para cd137. | |
PH12017501792A1 (en) | Recombinant binding proteins and their use | |
PH12017502286A1 (en) | Monoclonal antibodies against tissue factor pathway by inhibitor (tfpi) | |
JOP20220079A1 (ar) | بروتين ربط متعددة الخصوصية لمعالجة السرطان | |
CR20220618A (es) | Nuevas proteinas de unión a repeticiones de anquirina y sus usos | |
EP4285911A3 (en) | Methods and compositions for diagnosis and treatment of cancer | |
UA108193C2 (uk) | Апоптозіндукуючий засіб для лікування раку і імунних і аутоімунних захворювань | |
BR112018014288A2 (pt) | métodos e composições para o tratamento de doença neurológica | |
EA201201650A1 (ru) | Связывающие молекулы человека, имеющие убивающую активность против стафилококков, и их применения | |
MY167232A (en) | Polypeptides binding to human complement c5 | |
MX2021014601A (es) | Proteinas recombinantes de union a fap y su uso. | |
MX2011008429A (es) | Metodos y composiciones para diagnostico y tratamiento del cancer. | |
BR112012028893A2 (pt) | composições imunoestimuladoras e de vacina | |
MX2018000447A (es) | Novedosas proteinas especificas para lag-3. | |
AU2017329645A8 (en) | Novel antibodies against Factor XI and uses thereof | |
MX2023007067A (es) | Proteinas recombinantes de union a cd3 y su uso. | |
MX2021014649A (es) | Dominio de repetición de anquirina diseñado con estabilidad mejorada. | |
MX2019014365A (es) | Tratamiento topico de la enfermedad intestinal inflamatoria usando anticuerpos y fragmentos de los mismos. |